Looking Back at AONN+ Midyear 2026

News & Updates published on May 1, 2026 in News & Updates

It’s hard to believe that it’s already been two weeks since we wrapped up another incredible AONN+ Midyear Conference! It was a pleasure to welcome attendees both in person in Los Angeles and virtually – one of our most active and engaged online audiences to date!

Over four days, Midyear 2026 brought together oncology navigators and professionals from across the cancer care continuum for meaningful conversations, practical learning, and the kind of connection that reminds us just how special our community is.

From timely educational sessions like “The Digital Shift: How Technology Is Transforming Oncology Navigation,” to our first-ever “Innovation in Navigation Showcase,” attendees had the opportunity to explore new ideas, hear from experts and peers alike, and leave with insights they can bring back to their own patients and institutions.

Beyond the sessions themselves, Midyear was also a chance to reconnect with colleagues, build new relationships, and celebrate the work being done every day in the world of navigation.

Thank you to our faculty, attendees, partners, exhibitors, committee members, and staff for making Midyear possible. Your enthusiasm and commitment to improving patient care are what make this event so impactful year after year.

We hope to see all of you again in Dallas this November at our 17th Annual Navigation & Survivorship Conference!

Related Items
Colorectal Cancer Screening Update: with Andi Dwyer, MPH
News & Updates published on June 23, 2026 in News & Updates
In this interview, AONN+ Board of Trustees member Andi Dwyer discusses the American Cancer Society’s updated colorectal cancer screening guidelines, including new stool-based tests and the first-ever recommendation of an FDA-approved blood-based screening test, while emphasizing that colonoscopy and stool tests remain the most effective tools for early detection and prevention.
AONN+ Joins Pfizer’s 7th Annual Advocacy Luncheon at ASCO 2026
News & Updates published on June 23, 2026 in News & Updates
Pfizer’s 7th Annual Advocacy Luncheon at ASCO 2026 brought together advocacy leaders, including AONN+ Executive Director Candice Roth, MSN, RN, CENP, to discuss emerging cancer therapies, the role of artificial intelligence in patient-centered care, and the launch of Pfizer’s new Patient Advocacy360 partnership framework.
AONN+ Takes Part in CAR T Vision Coalition Event
News & Updates published on June 23, 2026 in News & Updates
Candice Roth, MSN, RN, CENP, and Monica Dean represented AONN+ at the launch of the first U.S. CAR T Vision to Action Blueprint, a stakeholder-driven initiative that provides practical strategies and tools to address access barriers and expand the use of CAR T-cell therapy for eligible patients nationwide by 2030.